The virtue of translational toxicology in drug discovery: selecting the right cinical candidate while reducing risk
- In: SHOWCASE CHINA on Wednesday, 16 April 2014, 16:00-17:20
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: JIN, Ren (Shanghai Institute of Materia Medica, Center for drug safety evaluation and research, Shanghai, China)
I. Background: Drug discovery is cost, time and risk intensive process. It takes ~one billion dollars and about 10-15 years to bring drug from concept to clinic. The majority of compounds do not progress from laboratory to patients, only 20% of the product enters the phase I trials eventually cleared the obstacle of FDA approval. The high.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.